Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:1678-1686
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, D.
Right arrow Articles by Thomas, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, D.
Right arrow Articles by Thomas, J. D.

EXPERIMENTAL STUDIES

Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration

Debabrata Mukherjee, MD*, James Wong, MD, PhD*, Brian Griffin, MD*, Stephen G. Ellis, MD*, Thomas Porter, MD{dagger}, Subha Sen, PhD* and James D. Thomas, MD, FACC*

* Cardiovascular Imaging Center, Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
{dagger} Department of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, USA

Manuscript received February 19, 1999; revised manuscript received November 18, 1999, accepted January 12, 2000.

Reprint requests and correspondence: Dr. James D. Thomas, Department of Cardiology, Desk F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195.
thomasj{at}cesmtp.ccf.org

OBJECTIVES

In this study, the feasibility of delivering and enhancing the uptake of vascular endothelial growth factor (VEGF) into the intact endothelium by using ultrasound (US) facilitation was determined.

BACKGROUND

A limitation of tissue-targeted drug delivery is the need for direct arterial cannulation. We postulate a mechanism by which agents injected intravenously may be targeted to a tissue using US and ultrasonic contrast agents.

METHODS

We used a rat model to test the ability of US and an ultrasonic contrast agent perflurocarbon exposed sonicated dextrose albumin (PESDA) to increase uptake of VEGF in the myocardium. Continuous wave Doppler US (0.6 W/cm2 at 1 MHz for 15 min) was applied to the chest wall overlying the myocardium during intravenous injection with either VEGF (100 µg/kg) alone or a combination of VEGF and PESDA (0.1%). Control rats had VEGF infused without US or PESDA. The VEGF uptake was measured quantitatively in the heart, lung, liver and kidneys by enzyme-linked immunosorbent assay (ng/g of tissue) and morphologically by fluorescence microscopy.

RESULTS

There was an eight-fold increase in VEGF uptake in the heart by US alone (16.86 ± 1.56 vs. 2.11 ± 0.953 ng/g of tissue, p < 0.0001) and a 13-fold increase with US + PESDA (26.78 ± 2.88 vs. 2.11 ± 0.953 ng/g of tissue, p < 0.0001) compared with control rats. Fluorescence microscopy revealed deposition of VEGF in the endothelium of small intramyocardial arterioles.

CONCLUSIONS

These results show a marked increase in endothelial VEGF uptake with US and US + PESDA. Thus, US may be used to augment endothelial VEGF uptake 10-fold to 13-fold.

Abbreviations and Acronyms
  CABG = coronary artery bypass grafting
  ELISA = enzyme-linked immunosorbent assay
  FITC = fluorescein isothiocyanate
  KHB = Krebs-Henseleit bicarbonate
  PBS = phosphate buffered saline
  PCNA = proliferating cells
  PESDA = perfluorocarbon-exposed sonicated dextrose albumin
  PTCA = percutaneous transluminal coronary angioplasty
  rhVEGF = recombinant human VEGF
  US = ultrasound
  VEGF = vascular endothelial growth factor
  vWF = von Willibrand factor




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. C. Chappell, J. Song, A. L. Klibanov, and R. J. Price
Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow-Derived Cells
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1117 - 1122.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. E. Stratmeyer, J. F. Greenleaf, D. Dalecki, and K. A. Salvesen
Fetal Ultrasound: Mechanical Effects
J. Ultrasound Med., April 1, 2008; 27(4): 597 - 605.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Chapman, J. Windle, F. Xie, A. McGrain, and T. R. Porter
Incidence of Cardiac Arrhythmias With Therapeutic Versus Diagnostic Ultrasound and Intravenous Microbubbles
J. Ultrasound Med., August 1, 2005; 24(8): 1099 - 1107.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Bekeredjian, P. A. Grayburn, and R. V. Shohet
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 329 - 335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Song, P. S. Cottler, A. L. Klibanov, S. Kaul, and R. J. Price
Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2754 - H2761.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. V. Pislaru, C. Pislaru, R. R. Kinnick, R. Singh, R. Gulati, J. F. Greenleaf, and R. D. Simari
Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities
Eur. Heart J., September 2, 2003; 24(18): 1690 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Takeuchi, K. Ohmori, I. Kondo, A. Oshita, K. Shinomiya, Y. Yu, Y. Takagi, K. Mizushige, K. Kangawa, and M. Kohno
Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats
Cardiovasc Res, April 1, 2003; 58(1): 231 - 238.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Song, M. Qi, S. Kaul, and R. J. Price
Stimulation of Arteriogenesis in Skeletal Muscle by Microbubble Destruction With Ultrasound
Circulation, September 17, 2002; 106(12): 1550 - 1555.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
R. J. Price and S. Kaul
Contrast Ultrasound Targeted Drug and Gene Delivery: An Update on a New Therapeutic Modality
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 171 - 180.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
J. Song, J. C. Chappell, M. Qi, E. J. VanGieson, S. Kaul, and R. J. Price
Influence of injection site, microvascular pressureand ultrasound variables on microbubble-mediated delivery of microspheres to muscle
J. Am. Coll. Cardiol., February 20, 2002; 39(4): 726 - 731.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. G. Amabile, J. M. Waugh, T. N. Lewis, C. J. Elkins, W. Janas, and M. D. Dake
High-efficiency endovascular gene delivery via therapeutic ultrasound
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1975 - 1980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Teupe, S. Richter, B. Fisslthaler, V. Randriamboavonjy, C. Ihling, I. Fleming, R. Busse, A. M. Zeiher, and S. Dimmeler
Vascular Gene Transfer of Phosphomimetic Endothelial Nitric Oxide Synthase (S1177D) Using Ultrasound-Enhanced Destruction of Plasmid-Loaded Microbubbles Improves Vasoreactivity
Circulation, March 5, 2002; 105(9): 1104 - 1109.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement